(a) A 60-year-old male presents with progressively increasing jaundice for 2 months. He is having clay coloured stools and pruritus. On examination, he is having a palpable and distended gall bladder.

(i) How will you investigate this patient? (5 ma

Question

(a) A 60-year-old male presents with progressively increasing jaundice for 2 months. He is having clay coloured stools and pruritus. On examination, he is having a palpable and distended gall bladder.

(i) How will you investigate this patient? (5 marks)
(ii) Briefly mention Courvoisier's law and its exceptions. (7 marks)
(iii) What are the treatment options for this patient? (8 marks)

(b) The Mother and Child Tracking System (MCTS) is a significant initiative of the government.

(i) Briefly explain what is MCTS. (5 marks)
(ii) What are its objectives? (5 marks)
(iii) How is it being put into operation? (5 marks)

(c) (i) How will you investigate a couple; wife 35 years, husband 37 years, married for 3 years, but trying for conception since 6 months? (5 marks)
(ii) What are the major factors affecting fertility? (5 marks)
(iii) Outline the treatment options available for unexplained infertility. (5 marks)

UPSC Answer Check · Accepted Answer

This question demands a structured, multi-part response covering surgical gastroenterology, public health systems, and reproductive medicine. Spend approximately 40% of the word budget on part (a) as it carries 20 marks (the highest weightage), with 25% each on parts (b) and (c) (10 marks each). Begin with a brief clinical vignette interpretation for (a), followed by systematic investigation algorithms, then transition to public health description for MCTS, and conclude with reproductive medicine protocols. Use bullet points and flowcharts where appropriate to maximize clarity within time constraints.
- For (a)(i): Investigation sequence for obstructive jaundice — USG abdomen first-line, followed by CT/MRCP, ERCP with biopsy, tumor markers (CA 19-9), and liver function tests showing conjugated hyperbilirubinemia with elevated alkaline phosphatase
- For (a)(ii): Courvoisier's law (painless palpable gallbladder with jaundice suggests malignancy, not stone disease) and its exceptions — pancreatic stone, choledocholithiasis with chronic cholecystitis, Mirizzi syndrome, and pancreatic head inflammatory mass
- For (a)(iii): Treatment options based on etiology — Whipple's procedure for resectable periampullary/head of pancreas cancer, palliative biliary stenting (ERCP/PTBD) for unresectable disease, chemotherapy (FOLFIRINOX/gemcitabine-nabpaclitaxel), and best supportive care
- For (b)(i)-(iii): MCTS as an ICT-based tracking system under NRHM (now part of RCH portal), objectives of ensuring ANC registration, institutional delivery, and complete immunization, with operation through ASHA/ANM data entry, SMS alerts to beneficiaries, and web-based monitoring dashboard
- For (c)(i)-(iii): Infertility workup — semen analysis, ovulation tracking (follicular monitoring), hysterosalpingography, hormonal profile (FSH, LH, AMH), and laparoscopy if indicated; factors affecting fertility (age, BMI, smoking, endometriosis, tubal factors, male factors); treatment for unexplained infertility — ovulation induction (clomiphene/letrozole), IUI, and IVF/ICSI as third-line

Dimension	Weight	Max marks	Excellent	Average	Poor
Concept correctness	20%	10	Demonstrates precise knowledge across all sub-parts: correctly identifies CA 19-9 and CEA for pancreatic malignancy workup in (a); accurately states Courvoisier's original 1890 observation and all four exceptions; correctly describes MCTS integration with RCH portal under NHM; names specific fertility markers (AMH, day 3 FSH) and WHO semen analysis criteria	Identifies basic investigations (USG, LFT) and knows Courvoisier's law superficially; describes MCTS as a tracking system without operational details; mentions general fertility tests (semen analysis, HSG) but misses specific protocols or cutoff values	Confuses Courvoisier's law with Charcot's triad or Murphy's sign; describes MCTS vaguely as 'mother and child program' without ICT component; suggests inappropriate first-line investigations (laparoscopy before semen analysis) or invents non-existent exceptions
Clinical correlation	20%	10	Integrates clinical findings seamlessly: explains why clay-colored stools + pruritus + palpable GB point to malignant biliary obstruction rather than viral hepatitis; correlates MCTS indicators with MDG/SDG targets (maternal mortality ratio, institutional delivery rates); applies age-related fertility decline (35-year threshold) to justify accelerated workup and IUI/IVF candidacy	Recognizes obstructive jaundice pattern but does not explain pathophysiology of pruritus (bile salt deposition); links MCTS to maternal health generally without specific outcome metrics; acknowledges 6-month trying period but does not justify early intervention for age ≥35	Misinterprets clinical picture as hemolytic jaundice or acute viral hepatitis; treats MCTS as clinical service rather than surveillance system; fails to recognize that 6 months trying at age 35+ constitutes infertility warranting evaluation
Diagram / pathway	20%	10	Includes clear algorithm for obstructive jaundice investigation (USG → CT/MRCP → ERCP/biopsy → staging); draws or describes MCTS workflow (registration → tracking → reminder → outcome); presents infertility evaluation flowchart with decision points based on semen analysis and ovulation status	Mentions need for algorithms but describes verbally without clear structure; lists MCTS components without showing data flow; outlines fertility tests in sequence but without decision-tree logic	No attempt at visual or structured representation; presents information as disconnected lists without logical progression; omits diagrams entirely despite explicit suitability for all three clinical scenarios
Differential / staging	20%	10	Comprehensive differentials for (a): pancreatic head cancer (most likely given Courvoisier-positive), periampullary carcinoma, cholangiocarcinoma, and benign strictures; mentions CT/MRCP-based staging (resectable vs. borderline vs. metastatic) and TNM for pancreatic cancer; for (c), differentiates primary vs. secondary infertility and classifies male/female/tubal/unexplained categories	Lists 2-3 differentials for jaundice (stones vs. cancer) without prioritization; mentions 'staging' generically without TNM or resectability criteria; for infertility, identifies male and female factors without systematic classification	Omits differential diagnosis entirely or provides irrelevant alternatives (hemolytic anemia, Gilbert syndrome); confuses staging systems; fails to classify infertility type or identify unexplained infertility as diagnosis of exclusion
Management / public-health angle	20%	10	For (a)(iii): details Whipple's pancreaticoduodenectomy components, neoadjuvant therapy for borderline resectable disease, palliative options (biliary stent types: plastic vs. metal, surgical bypass); for (b): critiques MCTS evolution into RCH portal, mentions HMIS integration and Aadhaar linkage challenges; for (c)(iii): evidence-based stepwise approach — expectant management 6-12 months, clomiphene/letrozole with IUI, then IVF/ICSI with success rates	Lists surgery, chemotherapy, and stenting without specifics; describes MCTS benefits without critical appraisal or implementation challenges; mentions IUI and IVF for unexplained infertility without sequencing or success rate context	Recommends inappropriate management (cholecystectomy alone for pancreatic cancer); treats MCTS purely as success story without operational reality; suggests empirical clomiphene without ovulation induction protocol or ignores male factor treatment

Q7

Directive word: Outline

How this answer will be evaluated

Approach

Key points expected

Evaluation rubric

Practice this exact question

More from Medical Science 2021 Paper II